Darotarotamide costs around $23,600 per box. Darotarotamide is an anticancer drug approved for marketing in 2021 for the treatment of adult patients with non-metastatic desmoplasia-resistant prostate cancer who are at high risk of metastasis. The domestic price is maintained at 23,600 yuan per box, but the specific price of or need to combine the purchase area, hospital grade, channel and other factors to determine, there is a certain price fluctuation. Darotamine as a non-steroidal androgen receptor inhibitor, its unique chemical structure and the receptor has a high affinity, showing strong antagonistic activity, so as to inhibit the function of the receptor and the growth of prostate cancer cells, to achieve shrinking the tumor, stabilize the condition effect. However, during the use of the drug, patients may experience adverse reactions such as fatigue, high blood pressure and nausea, and need to use the drug under the guidance of a doctor.